Clinical Research on Moderately Hypofractionated Adaptive Postoperative Radiotherapy for High-Risk Endometrial Cancer

Clinical trial NCT07116213 · RECRUITING

Trial details

NCT number: NCT07116213
Sponsor: Xiaorong Hou
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Endometrial Cancer Hypofractionated Dose Radiotherapy, Adjuvant Side Effects Survival , Tumor

Start date: 2025-06-30
Primary completion: 2029-06-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.